NCCIH and complementary approaches during cancer

The National Center for Complementary and Integrative Health is one of the 27 Institutes, Centers, and Offices that make up the National Institutes of Health. It was established in October 1998. It is the federal government's lead agency for scientific research on health practices that sit outside conventional medicine.

That last sentence matters more than it looks. NCCIH studies these approaches. Studying something is not the same as recommending it. A study can find that a practice helps. It can also find that a practice does nothing, or that it causes harm. All three results are useful science.

NCCIH states its mission plainly. It exists to determine, through rigorous scientific investigation, the fundamental science, usefulness, and safety of complementary and integrative health approaches. Note that safety sits in the mission alongside usefulness. The agency is not only asking whether something works. It is also asking whether it hurts.

NCCIH separates three terms, and the difference is worth learning because people use them loosely.

• Complementary means used together with conventional medicine.
• Alternative means used in place of conventional medicine.
• Integrative health means conventional and complementary approaches brought together in a coordinated way, with attention to the whole person.

The gap between the first and the second is the important one. Adding a gentle practice alongside your oncology care is a different decision from replacing that care. NCCIH also notes that in a national survey, most American adults who used non-mainstream approaches continued their conventional care as well.

Three things, really.

It can give you plain-language summaries. NCCIH publishes pages that walk through what the research has actually found on specific practices and products, in ordinary English, without a sales pitch attached.

It can tell you where the evidence is thin. This is its most useful service. NCCIH is direct that research on dietary supplements has often found the products did not work for the conditions studied. It also says more research is needed on how supplements act in the human body, on their safety, and on their potential interactions with medicines.

It can help you ask better questions. Once you know what has and has not been studied, the conversation with your oncology team changes. You stop asking whether something is good. You start asking whether it is safe for you.

It is a federal agency, so all of this is free to read.

It cannot treat you. NCCIH is not a clinic. It does not manage anyone's cancer care.

It cannot endorse a product or a brand. There is no NCCIH seal of approval, and anyone claiming one is misrepresenting the agency. If a supplement bottle or a website hints that NCCIH backs it, that is marketing, not government.

It cannot answer questions about your own body. NCCIH says directly that its material is not intended to substitute for the medical expertise and advice of your own health care providers. It does not know your diagnosis, your drugs, your doses, your liver and kidney function, or your surgery date.

And it cannot resolve uncertainty that the science has not resolved yet. When the honest answer is that nobody knows, NCCIH will say so. That is the agency working correctly, even though it is frustrating to read.

This is the part that deserves the most care during cancer treatment.

Cancer treatments are powerful, and many are processed by the same liver pathways that handle herbs and supplements. A product can change how much of a drug ends up in your blood. Too little and the treatment underperforms. Too much and the side effects get worse. Some products affect bleeding, which matters before surgery or a biopsy. Some can affect blood counts or liver tests, which can muddy the results your team relies on.

None of that is visible from the label. A product can be plant-based, sold in a pharmacy, recommended by someone kind who loves you, and still be a bad idea this month.

Bring the actual containers to your appointment. Not a list from memory. The bottles, the tea, the powder, the drops.

Let your oncology team read the labels. Ask whether anything needs to stop, whether anything needs to pause around treatment days, and whether anything should be watched with a blood test. Ask whether the hospital has a supportive care or integrative medicine service, because many cancer centers do.

That is the whole system working as intended. NCCIH does the research and publishes what it finds. Your care team applies it to you.